Back to companies

Smith & Nephew Plc: Premium Databases

Smith & Nephew Plc Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

A sample of Smith & Nephew Plc Insights data

Headline Published Journalists
Showing 3 of 3 results. Subscribe to unlock more.
Deserunt mollit sunt Lorem laborum do id aliqua dolore 28 Nov 2018 Lorem
Incyte’s Phase III itacitinib sparks uncertainty on JAK1 selectivity's advantage in acute GVHD vs its JAK1/JAK2 inhibitor in sNDA review 28 Nov 2018 Mariana Lenharo
Gottlieb’s leadership to see cell therapies, generics hit the market faster, but budget, staffing challenges remain – experts 19 May 2017 Fiona Barry
Osiris’ stem cell therapy Prochymal faces reservations in Phase III Crohn’s trial – experts 01 Nov 2012 Surani Fernando
Insights

Feature

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Benefit

Drug Insights:

  • Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
  • Material intelligence on competitors, including breaking news
  • Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Value

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer